Thrombotic microangiopathy and occult neoplasia

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 10, Issue 2, 2010, Pages 87-93

  Pirrotta, Maria Teresa ^a   Bucalossi, Alessandro ^b  

^a SAN GIUSEPPE HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Occult malignancy; Thrombotic microangiopathies

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOCORTICOID; LIVER ENZYME; RITUXIMAB; VON WILLEBRAND FACTOR;

ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CLINICAL FEATURE; HELLP SYNDROME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LABORATORY TEST; MICROANGIOPATHY; OCCULT CANCER; PLASMAPHERESIS; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; BLOOD; NEOPLASM; PATHOLOGY; VASCULARIZATION;

HUMANS; NEOPLASMS; THROMBOTIC MICROANGIOPATHIES;

EID: 77953653671     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152910791292475     Document Type: Article

References (46)

1. Trousseau, A. Plegmasia alba dolens. Lecture on clinical medicine, delivered at the Hotel-Dieu, Paris. London: New Sydenham Society, 1872, pp. 281-295.
2. Bick, R.L. Alterations of haemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management. Semin. Thromb. Hemost, 1978, 5, 1-26.
3. Schafer, A.I. Bleeding and thrombosis in the myeloproliferative disorders. Blood, 1987, 69, 187-191.
4. Loreto, M.F.; De Martinis, M.; Corsi, M.P.; Modesti, M.; Ginaldi, L. Coagulation and cancer: implications for diagnosis and management. Pathol. Oncol. Res., 2000, 6, 301-312.
5. Gordon, L.I.; Kwaan, H.C. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/haemolytic uremic syndrome in the cancer patient. Semin. Thromb. Haemost., 1999, 25, 217-221.
6. Mannucci, P.M.; Karimi, M.; Mosalaei A.; Canciani, M.T.; Peyvandi, F. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease). Haematologica, 2003, 88, 454-458.
7. Moschcowitz, E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc. N.Y. Pathol. Soc, 1924, 24, 21-24.
8. Amorosi, E.L.; Ultmann, J.E. Thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine, 1966, 45, 139-159.
9. George, J.N. How I treat patients with thrombotic thrombocy-topenic purpura-hemolytic uremic syndrome. Blood, 2000, 96, 1223-1229.
10. Bell, W.R.; Braine, H.G.; Ness, P.M.; Kickler, T.S. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N. Engl. J. Med., 1991, 525, 398-403.
11. Furlan, M.; Robles, R.; Solenthaler, M.; Wassmer, M.; Sandoz, P.; Lammle, B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 1997, 89, 3097-3103.
12. Tsai, H.M.; Lian, E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N. Engl. J. Med., 1998, 339, 1585-1594.
13. McCrae, K. R.; Cines, D.B. Thrombotic microangiopathy during pregnancy. Semin. Hematol., 1997, 34, 148-158.
14. Medina, P.J.; Sipols, J.M.; George, J.N. Drug-associated throm-botic thrombocytopenic purpura-hemolytic uremic syndrome. Curr. Opin. Hematol., 2001, 8, 286-293.
15. George, J.N.; Selby, G.B. Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes. Bone Marrow Transplant., 2004, 33, 1073-1074.
16. Zheng, X.L.; Sadler, J.E. Pathogenesis of thrombotic microan-giopathies. Ann. Rev. Pathol., 2008, 3, 249-277.
17. Terrell, D.R.; Williams, L.A.; Vesely, S.K.; Lammle, B.; Hoving, J.A.; George, J.N. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J. Thromb. Haemost., 2005, 3, 1432-1436.
18. Lohrmann, H.P.; Adam, W.; Heymer, B.; Kubanek, B. Micronagiopathic haemolytic anemia in metastatic carcinoma. Report of eight cases. Ann. Intern. Med., 1973, 79, 368-375.
19. Ruutu, T,; Barosi, G.; Benjamin, R.J.; Clark, R.E.; George, J.N.; Gratwohl, A.; Holler, E.; Iacobelli, M.; Kentouche, K.; Lammle, B.; Moake, J.L.; Richardson, P.; Socie, G.; Zeigler, Z.; Niederwie-ser, D.; Barbui, T. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica, 2007, 92, 95-100.
20. Dashe, J.S.; Ramin, S.M.; Cunningham, F.G. The long-term consequences of thrombotic microangiopathy (thrombotic thrombocy-topenic purpura and haemolytic uremic syndrome) in pregnancy. Obstet. Gynecol., 1998, 91, 662-668.
21. Gasser, C.; Gautier, E.; Steck, A.; Siebenmann, R.E.; Oechslin, R. Hemolytic uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz. Med. Wochenschr., 1955, 85, 905-909.
22. Copelovitch, L.; Kaplan, B.S. The thrombotic microangiopathies. Pediatr. Nephrol., 2008, 23, 1761-1767.
23. Coppo, P.; Veyradier, A. Thrombotic microangiopathies: towards a pathophysiology-based classification. Cardiovasc. Hematol. Disord. Drugs Targets, 2009, 9, 36-50.
24. Skerka, C.; Jozsi, M.; Zipfel, P.F.; Dragon-Durey, M.A.; Fremeaux-Bacchi, V. Autoantibodies in haemolytic uremic syndrome (HUS). Thromb. Haemost., 2009, 101, 227-232.
25. Delvaeye, M.; Noris, M.; De Vriese, A.; Esmon, N.L.; Ferrel, G.; Del Favero, J.; Plaisance, S.; Claes, B.; Lambrechts, D.; Zoja, C.; Remuzzi, G.; Conway, E.M. Thrombomodulin mutations in atypical haemolytic-uremic syndrome. N. Engl. J. Med., 2009, 361, 345-357.
26. Symmers, W. Thrombotic microangiopathic haemolytic anemia (thrombotic microangiopathy). Br. Med. J., 1952, ii, 897-903.
27. George, J.N.; Selby, G.B. Thrombotic microangiopathy after allogenic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes. Bone Marrow Transplant., 2004, 33, 1073-1074.
28. Tsai, H.M. Molecular mechanisms in thrombotic thrombocytopenic purpura. Sem. Thromb. Hemost., 2004, 30, 549-557.
29. Mc Leod, B.C. Thrombotic microangiopathies in bone marrow and organ transplant patients. J. Clin. Apheresis, 2002, 17, 118-123.
30. Murgo, A.J. Trhombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin. Hema-tol., 1987, 24, 161-177.
31. Kressel, B.R.; Ryan, K.P.; Doung, A.T.; Berenberg, J.; Schein, P.S. Microangiopathic hemolytic anemia, thrombocytopenia and renal failure in patients treated for adenocarcinoma. Cancer, 1981, 48, 1738-1745.
32. Kwaan, H.C.; Gordon, L.I. Thrombotic Microangiopathy in the cancer patient. Acta Haematol., 2001, 106, 52-56.
33. Medina, P.J.; Sipols, J.; George, J.N. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr. Opin. Hematol., 2001, 8, 286-293.
34. Zakarija, A.; Bennett, C. Drug-induced thrombotic microangiopathy. Semin. Thromb. Hemost., 2005, 31, 681-690.
35. Schriber, J.R.; Herzig, G.P. Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin. Hematol., 1997, 34, 126-133.
36. Francis, K.K.; Kalyanam, N.; Terrell, D.R.; Vesely, S.K., George, J.N. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases. Oncologist, 2007, 12, 11-19.
37. Hahn, H.; Ha, I.S.; Choi, H.S.; Shin, H.Y.; Cheong, H.I.; Ahn, H.S.; Choy, Y. Acute leukemia: an association with atypical hemolytic uremic syndrome. Pediatr. Nephrol., 2003, 18, 703705.
38. Still, H.; Hofler, G.; Kaufmann, P.; Horina, J.; Spuller, E.; Kleinert, R.; Beham-Scmid, C. Angiotropic large cell lymphoma presenting as thrombotic microangiopathy (thrombotic thrombocytopenic pur-pura). Cancer, 1995, 75, 1167-1170.
39. Qu, L.; Kiss, J.E. Thrombotic microangiopathy in transplantation and malignancy. Semin. Thromb. Hemost., 2005, 31, 691-699.
40. von Bubnoff, N.; Sandherr, M.; Schneller, F.; Peschel, C. Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast. Am. J. Clin. Oncol., 2000, 23, 74-77.
41. Brain, M.C.; Azzopardi, J.G.; Baker, L.R.; Pineo, G.F.; Roberts, P.D.; Dacie, J.V. Microangiophatic haemolytic anaemia and mucin-forming adenocarcinoma. Br. J. Haematol., 1970, 18, 183-192.
42. Antman, K.H.; Skarin, A.T.; Mayer, R.J.; Hargreaves, H.K.; Canel-los, G.P. Microangiopathic hemolytic anemia and cancer: a review. Medicine, 1979, 58, 377-384.
43. Werner, T.L.; Agarwal, N.; Carney, H.M.; Rodgers, G.M. Management of cancer-associated thrombotic microangiopathy: what is the right approach? Am. J. Hematol., 2007, 82, 295-298.
44. Pirrotta, M.T.; Bucalossi, A.; Forconi, F.; Bocchia, M.; Mazzotta, S.; Sammassimo, S.; Gozzetti, A.; Lauria, F. Thrombotic thrombo-cytopenic purpura secondary to an occult adenocarcinoma. Oncologist, 2005, 10, 299-300.
45. Oberic, L.; Buffet, M.; Schwarzinger, M.; Veradier, A.; Clabault, K.; Malot, S.; Schleinitz, N.; Valla, D.; Galicier, L.; Bengrine-Lefevre, L.; Gorin, N.C.; Coppo, P. Cancer awareness in atypical thrombotic microangiopathies. Oncologist, 2009, 14, 780-793.
46. Murgo, A. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin. Hema-tol., 1987, 24, 161-177.